Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice. (2019)

First Author: Recino A
Attributed to:  UKDP: Integrated DEmentiA research environment (IDEA) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41434-018-0052-5

PubMed Identifier: 30514969

Publication URI: http://europepmc.org/abstract/MED/30514969

Type: Journal Article/Review

Volume: 26

Parent Publication: Gene therapy

Issue: 1-2

ISSN: 0969-7128